We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Notifications of infectious diseases (NOIDs) and reportable causative organisms: legal duties of laboratories and medical practitioners.
Information about UK Health Security Agency's tick awareness resources and how to take part in the Tick Surveillance Scheme.
Toolkit and resources for local authorities and other stakeholders to raise awareness of the potential risks created by ticks and tick-borne disease in England.
Advice on the recognition, investigation and management of Panton-Valentine Leukocidin (PVL)-Staphylococcus aureus (PVL-SA) cases.
Guidance on who to test for Zika virus infection and which samples to collect.
Guidance on reducing the risk of getting MERS-CoV for UK residents and travellers to the Middle East.
The characteristics, diagnosis, treatment, and epidemiology of group B streptococci.
This service allows hospitals to record incidents of infection after surgery, track patient results and review or change practice to avoid further infections.
The symptoms and epidemiology of giardiasis including travel-associated infections.
Guidance on the collection and reporting of data for GUMCAD, the surveillance system for sexually transmitted infections (STIs) in England.
Guidance for health protection teams on the investigation of cases, clusters and outbreaks of Legionnaires’ disease.
UKHSA's role as National Focal Point for communication of public health events to the WHO under the International Health Regulations (2005).
These guidelines on prevention of secondary disease have been developed following a review of the epidemiology of invasive Hib disease.
Summary of the risk assessment processes used by the Human Animal Infections Risk Surveillance group to identify, assess and report potential infectious threats.
An overview of the National Chlamydia Screening Programme (NCSP).
Guidance for screening providers and commissioners on conducting health equity audits (HEAs)
This document sets out an overview of the operational pathways in the NHS Diabetic Eye Screening (DES) programme.
Guidance for commissioners and providers on evaluating local chlamydia activities to improve outcomes for users and services.
This privacy notice explains the personal information we collect on individuals as part of SSBBV testing, how we use it and who we may share it with.
Standards for providers and commissioners of chlamydia screening, part of the National Chlamydia Screening Programme (NCSP).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).